NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.89% | -6.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.89% | -6.14% | |||
| Cost of Revenue | 0.00% | -5.29% | |||
| Gross Profit | -4.68% | -9.59% | |||
| SG&A Expenses | 9.03% | 5.27% | |||
| Depreciation & Amortization | -0.15% | -2.53% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.32% | -3.80% | |||
| Operating Income | -98.59% | -54.73% | |||
| Income Before Tax | -1,589.56% | -94.86% | |||
| Income Tax Expenses | -136.57% | -19.25% | |||
| Earnings from Continuing Operations | -251.32% | -127.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -25.70% | 29.49% | |||
| Net Income | -164.09% | -159.57% | |||
| EBIT | -98.59% | -54.73% | |||
| EBITDA | -21.74% | -36.67% | |||
| EPS Basic | -160.00% | -160.61% | |||
| Normalized Basic EPS | -266.67% | -75.41% | |||
| EPS Diluted | -160.00% | -160.61% | |||
| Normalized Diluted EPS | -266.67% | -74.58% | |||
| Average Basic Shares Outstanding | -0.41% | -0.22% | |||
| Average Diluted Shares Outstanding | -3.51% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||